CoChat

Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease

Open access
Bayliss, Jacqueline A., Lemus, Moyra B., Stark, Romana, Santos, Vanessa V., Thompson, Aiysha, Rees, Daniel J., Galic, Sandra, Elsworth, John D., Kemp, Bruce E., Davies, Jeffrey S., Andrews, Zane B. · 2016 · The Journal of Neuroscience
Cited by 159

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Calorie restriction (CR) is neuroprotective in Parkinson's disease (PD) although the mechanisms are unknown. In this study we hypothesized that elevated ghrelin, a gut hormone with neuroprotective properties, during CR prevents neurodegeneration in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD. CR attenuated the MPTP-induced loss of substantia nigra (SN) dopamine neurons and striatal dopamine turnover in ghrelin WT but not KO mice, demonstrating that ghrelin mediates CR's neuroprotective effect. CR elevated phosphorylated AMPK and ACC levels in the striatum of WT but not KO mice suggesting that AMPK is a target for ghrelin-induced neuroprotection. Indeed, exogenous ghrelin significantly increased pAMPK in the SN. Genetic deletion of AMPKβ1 and 2 subunits only in dopamine neurons prevented ghrelin-induced AMPK phosphorylation and neuroprotection. Hence, ghrelin signaling through AMPK in SN dopamine neurons mediates CR's neuroprotective effects. We consider targeting AMPK in dopamine neurons may recapitulate neuroprotective effects of CR without requiring dietary intervention. SIGNIFICANCE STATEMENT The neuroprotective mechanisms of calorie restriction (CR) in Parkinson's disease are unknown. Indeed, the difficulty to adhere to CR necessitates an alternative method to recapitulate the neuroprotective benefits of CR while bypassing dietary constraints. Here we show that CR increases plasma ghrelin, which targets substantia nigra dopamine to maintain neuronal survival. Selective deletion on AMPK beta1 and beta2 subunits only in DAT cre-expressing neurons shows that the ghrelin-induced neuroprotection requires activation of AMPK in substantia nigra dopamine neurons. We have discovered ghrelin as a key metabolic signal, and AMPK in dopamine neurons as its target, which links calorie restriction with neuroprotection in Parkinson's disease. Thus, targeting AMPK in dopamine neurons may provide novel neuroprotective benefits in Parkinson's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4373-15.2016

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 36

  1. 10.1074/jbc.C300557200 · DOI · Paper page
  2. 10.2174/1874609811003020102 · DOI
  3. 10.1080/07315724.1997.10718679 · DOI · Paper page
  4. 10.1155/2014/692061 · DOI · Paper page
  5. 10.1155/2014/203930 · DOI
  6. 10.1016/j.bbrc.2009.11.022 · DOI
  7. 10.1016/j.freeradbiomed.2004.12.008 · DOI
  8. 10.1007/s12031-008-9162-7 · DOI
  9. 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P · doi:10.1002/(sici)1097-4547(19990715)57:2<195::aid-jnr5>3.0.co;2-p
  10. 10.1016/j.nbd.2013.11.002 · DOI · Paper page
  11. 10.1016/j.mad.2004.06.011 · DOI
  12. 10.1046/j.0953-816x.2001.01649.x · DOI
  13. 10.1002/ejp.511 · DOI
  14. 10.18632/aging.100616 · DOI · Paper page
  15. 10.1002/syn.20163 · DOI · Paper page
  16. 10.1016/j.psyneuen.2015.09.023 · DOI · Paper page
  17. 10.1016/j.nbd.2011.03.005 · DOI
  18. 10.1016/j.neurobiolaging.2012.11.001 · DOI · Paper page
  19. 10.1016/j.ejphar.2008.10.005 · DOI · Paper page
  20. 10.1074/jbc.C500175200 · DOI · Paper page
  21. 10.1002/jcb.22580 · DOI · Paper page
  22. 10.1073/pnas.0405831102 · DOI · Paper page
  23. 10.1016/j.cmet.2014.04.007 · DOI · Paper page
  24. 10.1006/exnr.1994.1058 · DOI · Paper page
  25. 10.1523/JNEUROSCI.0499-12.2012 · DOI · Paper page
  26. 10.1113/jphysiol.2006.109512 · DOI · Paper page
  27. 10.1016/j.cmet.2007.01.008 · DOI · Paper page
  28. 10.1016/0006-8993(90)91055-L · DOI
  29. 10.1196/annals.1404.023 · DOI
  30. 10.1016/j.brainres.2013.02.046 · DOI · Paper page
  31. 10.1210/en.2006-0782 · DOI
  32. 10.1210/en.2009-0633 · DOI
  33. 10.1016/j.peptides.2007.07.030 · DOI
  34. 10.5115/acb.2011.44.3.194 · DOI
  35. 10.1073/pnas.1002271107 · DOI · Paper page
  36. 10.1089/ars.2013.5587 · DOI

Cited by

See all 159

Metadata

Authors
Bayliss, J. A., Lemus, M. B., Stark, R., Santos, V. V., Thompson, A., Rees, D. J., Galic, S., Elsworth, J. D., Kemp, B. E., Davies, J. S., & Andrews, Z. B.
Venue
The Journal of Neuroscience
Published
2016-03-09
Volume
36
Issue
10
Pages
3049-3063
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2264754526
Cited by
159
References
18
FWCI
13.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease. https://app.cochat.ai/papers/10.1523/jneurosci.4373-15.2016
The paper
Bayliss, J. A., Lemus, M. B., Stark, R., Santos, V. V., Thompson, A., Rees, D. J., Galic, S., Elsworth, J. D., Kemp, B. E., Davies, J. S., & Andrews, Z. B. (2016). Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4373-15.2016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.